Strides Pharma Share: Q4 Profit **51%** Bhaga! Ex-US Sales Ne Machaya Dhamal

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Strides Pharma Share: Q4 Profit **51%** Bhaga! Ex-US Sales Ne Machaya Dhamal
Overview

Strides Pharma ke liye Q4 result ekdum zabardast rahe! Company ka net profit **51%** badh kar **₹129.28 Crore** tak pahunch gaya, mainly markets outside USA mein solid performance ki wajah se. Revenue bhi badha hai, strategy achhi chal rahi hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Profit Mein Toofani Tezi Ka Reason?

Bro, Strides Pharma Science ne FY26 ke liye Q4 results announce kiye hain aur numbers kamaal ke hain! Company ka net profit 51% jump karke ₹129.28 Crore ho gaya, jo pichhle saal ₹85.62 Crore tha. Iske peeche sabse bada haath hai ex-US markets ka. Yahan revenue ₹645.8 Crore ho gaya, jo pichhle saal sirf ₹480 Crore tha. US market thoda stable raha, ₹646.7 Crore ke aas-paas, jo pichhle saal ₹651.5 Crore tha. Total revenue bhi ₹1,323.47 Crore ho gaya, up from ₹1,190.39 Crore.

Poore Saal Ka Haalchaal

FY26 ke liye poore saal ka consolidated net profit ₹574.52 Crore raha. FY25 mein yeh number kaafi bada tha (₹3,597.51 Crore), lekin woh ek one-time profit ki wajah se tha jo FY26 mein nahi tha. Poore saal ka revenue ₹4,858.68 Crore raha, jo FY25 ke ₹4,565.34 Crore se zyada hai.

CEO Kya Bol Rahe Hain Aur Investors Ke Liye Kya?

MD & Group CEO Badree Komandur ne kaha ki ex-US markets mein unki strategy mast kaam kar rahi hai aur growth ko boost de rahi hai. US market stable raha, lekin flu season thoda weak hone se impact hua. Geopolitical tensions aur tough environment ke bawajood, Komandur ne future mein sustainable aur profitable growth ki commitment dikhai hai. Board ne ₹5 per equity share ka final dividend recommend kiya hai, jo 50% payout hai. Yeh company ke confidence aur shareholders ke liye achha sign hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.